Juan E. Vericat-Megias

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Improvements in pharmacokinetics, bleeding control, and cost analysis after PK-guided transition to extended-half-life factor IX in hemophilia B: A multicentric study.

Improvements in pharmacokinetics, bleeding control, and cost analysis after PK-guided transition to extended-half-life factor IX in hemophilia B: A multicentric study.

Journal: Thrombosis research

Published: October 28, 2025

Real-World Assessment of Pharmacokinetics, Clinical Outcomes, and Costs After Switching from Standard Half-Life to Extended Half-Life FVIII in Well-Controlled Hemophilia A Patients.

Real-World Assessment of Pharmacokinetics, Clinical Outcomes, and Costs After Switching from Standard Half-Life to Extended Half-Life FVIII in Well-Controlled Hemophilia A Patients.

Journal: Hematology reports

Published: August 24, 2025

Budget impact analysis of Haemate-P as long-term prophylaxis and on-demand therapy for von Willebrand disease in Spain.

Budget impact analysis of Haemate-P as long-term prophylaxis and on-demand therapy for von Willebrand disease in Spain.

Journal: Journal of medical economics

Published: July 18, 2025

Cost-effectiveness and cost-utility analysis of Haemate-P versus other von Willebrand disease treatments in Spain.

Cost-effectiveness and cost-utility analysis of Haemate-P versus other von Willebrand disease treatments in Spain.

Journal: Journal of medical economics

Published: March 07, 2025

Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.

Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.

Journal: European journal of clinical pharmacology

Published: February 19, 2025

Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Journal: International journal of molecular sciences

Published: January 16, 2025

[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: July 06, 2024

Mental, emotional and social dimensions of quality of life and their relationship with physical and functional status in adults with haemophilia.

Mental, emotional and social dimensions of quality of life and their relationship with physical and functional status in adults with haemophilia.

Journal: Thrombosis research

Published: May 05, 2024

Development and testing of a mobile app for systematic collection of patient-reported outcomes (PROs) in patients with hemophilia.

Development and testing of a mobile app for systematic collection of patient-reported outcomes (PROs) in patients with hemophilia.

Journal: Thrombosis research

Published: May 04, 2024

Benefits of physical activity self-monitoring in patients with haemophilia: a prospective study with one-year follow-up.

Benefits of physical activity self-monitoring in patients with haemophilia: a prospective study with one-year follow-up.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: November 15, 2023

New challenges of advanced therapies.

New challenges of advanced therapies.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: September 18, 2023

[Translated article] New challenges in advanced therapies.

[Translated article] New challenges in advanced therapies.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: September 18, 2023

Showing 1-12 of 67

Last Updated: 09/26/2026